Paper38982016
Mitochondrial targeted antioxidants as potential therapy for huntington's disease.
Upadhayay S and 1 other. Pharmacol Rep, 2024. Cited by 23 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Mitochondrial targeted antioxidants as potential therapy for huntington's disease. Papers, record 38982016. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38982016
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Huntington Disease | Major topic |
| Antioxidants | Major topic |
| Mitochondria | Major topic |
| Neuroprotective Agents | Major topic |
| Humans | |
| Animals | |
| Oxidative Stress |
Source PubMed
References132
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23,220,289 | Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases. | Mol Cell Neurosci | 2013 | https://conductscience.org/library/papers/23220289 | PubMed |
| 2 | 18,607,213 | Pathophysiology of Huntington's disease: from huntingtin functions to potential treatments. | Curr Opin Neurol | 2008 | https://conductscience.org/library/papers/18607213 | PubMed |
| 3 | 30,616,867 | Recent advances in the therapeutic development for Huntington disease. | Parkinsonism Relat Disord | 2019 | https://conductscience.org/library/papers/30616867 | PubMed |
| 4 | 37,042,034 | Animal models of Huntington's disease and their applicability to novel drug discovery and development. | Expert Opin Drug Discov | 2023 | https://conductscience.org/library/papers/37042034 | PubMed |
| 5 | 35,829,908 | Computational insights into missense mutations in HTT gene causing Huntington's disease and its interactome networks. | Ir J Med Sci | 2023 | https://conductscience.org/library/papers/35829908 | PubMed |
| 6 | 35,865,413 | Huntington's disease iPSC models-using human patient cells to understand the pathology caused by expanded CAG repeats. | Fac Rev | 2022 | https://conductscience.org/library/papers/35865413 | PubMed |
| 7 | 34,319,843 | Emerging therapeutics in Huntington's disease. | Expert Opin Emerg Drugs | 2021 | https://conductscience.org/library/papers/34319843 | PubMed |
| 8 | 36,752,239 | The Prevalence of Huntington Disease in Asia Highlights Needs in Clinical, Genetic and Instrumental Diagnosis: A Systematic Review and Meta-Analysis. | Psychiatr Danub | 2022 | https://conductscience.org/library/papers/36752239 | PubMed |
| 9 | 37,269,968 | Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review. | Mitochondrion | 2023 | https://conductscience.org/library/papers/37269968 | PubMed |
| 10 | 30,941,017 | Mitochondrial Dysfunction in Huntington's Disease; Interplay Between HSF1, p53 and PGC-1α Transcription Factors. | Front Cell Neurosci | 2019 | https://conductscience.org/library/papers/30941017 | PubMed |
| 11 | 16,973,623 | Mutant huntingtin expression induces mitochondrial calcium handling defects in clonal striatal cells: functional consequences. | J Biol Chem | 2006 | https://conductscience.org/library/papers/16973623 | PubMed |
| 12 | 30,081,095 | Mitochondrial permeability transition pore: a potential drug target for neurodegeneration. | Drug Discov Today | 2018 | https://conductscience.org/library/papers/30081095 | PubMed |
| 13 | 9,740,408 | Astrocytes are more vulnerable than neurons to cellular Ca2+ overload induced by a mitochondrial toxin, 3-nitropropionic acid. | Neuroscience | 1998 | https://conductscience.org/library/papers/9740408 | PubMed |
| 14 | 19,799,953 | Discriminative behavioral assessment unveils remarkable reactive astrocytosis and early molecular correlates in basal ganglia of 3-nitropropionic acid subchronic treated rats. | Neurochem Int | 2010 | https://conductscience.org/library/papers/19799953 | PubMed |
| 15 | 36,724,946 | 3-Nitropropionic Acid Enhances Ferroptotic Cell Death via NOX2-Mediated ROS Generation in STHdhQ111 Striatal Cells Carrying Mutant Huntingtin. | Biol Pharm Bull | 2023 | https://conductscience.org/library/papers/36724946 | PubMed |
| 16 | 21,237,233 | Licofelone attenuates quinolinic acid induced Huntington like symptoms: possible behavioral, biochemical and cellular alterations. | Prog Neuropsychopharmacol Biol Psychiatry | 2011 | https://conductscience.org/library/papers/21237233 | PubMed |
| 17 | 32,998,277 | Neuroprotective Effect of Antioxidants in the Brain. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32998277 | PubMed |
| 18 | 35,988,447 | Mitochondrial and redox modifications in early stages of Huntington's disease. | Redox Biol | 2022 | https://conductscience.org/library/papers/35988447 | PubMed |
| 19 | 29,427,098 | Mitochondrial Dysfunction in Huntington's Disease. | Adv Exp Med Biol | 2018 | https://conductscience.org/library/papers/29427098 | PubMed |
| 20 | 35,974,214 | Research Progress of Long Non-coding RNAs in Spinal Cord Injury. | Neurochem Res | 2023 | https://conductscience.org/library/papers/35974214 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,823,496 | Therapeutic role of fucoidans against oxidative stress: recent developments, translational challenges, and future directions. | Arch Toxicol | 2026 | https://conductscience.org/library/papers/42823496 | PubMed |
| 42,616,200 | The potential of vitamins in Huntington's disease: bridging mechanistic evidence with translational limitations and future strategies. | Metab Brain Dis | 2026 | https://conductscience.org/library/papers/42616200 | PubMed |
| 42,609,516 | Cell Death in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42609516 | PubMed |
| 42,237,308 | Neuroprotective potential of esterified indole-3-propionic acid with curcumin against high glucose stress: targeting oxidative damage, Akt/mTOR, and BDNF/TrkB pathways. | BMC Pharmacol Toxicol | 2026 | https://conductscience.org/library/papers/42237308 | PubMed |
| 42,204,067 | Mitochondrial dysfunction in neurodegenerative disorders: mechanisms and therapeutic advances. | Mol Biomed | 2026 | https://conductscience.org/library/papers/42204067 | PubMed |
| 41,870,813 | Role of Pentacyclic Triterpenes in the Management of Neurological Disorders: An Insight into Molecular Mechanisms and Therapeutic Approaches. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/41870813 | PubMed |
| 41,830,183 | Mechanisms and therapeutic potential of mitochondrial-targeted therapies in bone repair. | Ann Med | 2026 | https://conductscience.org/library/papers/41830183 | PubMed |
| 41,762,337 | Roflumilast Elicits Therapeutic and Neuroprotective Effects in 3-Nitropropionic Acid-Induced Huntington's Disease-Like Neurodegeneration in Rats by Mitigating NLRP3 Inflammasome-Mediated Pyroptosis, Ferroptosis, and Glial Activation. | Neurochem Res | 2026 | https://conductscience.org/library/papers/41762337 | PubMed |
| 41,720,188 | Unraveling Riboflavin-Mediated Mitochondrial Modulation as a Therapeutic Pathway in Neurological Disorders: An Integrative Systematic Review. | J Nutr | 2026 | https://conductscience.org/library/papers/41720188 | PubMed |
| 41,703,162 | Alisol A Mitigates Neuroinflammation and Oxidative Stress After Subarachnoid Hemorrhage Through SIRT3-Driven Reprogramming of Mitochondrial Metabolism. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/41703162 | PubMed |
| 41,693,955 | Dietary and metabolic reprogramming alleviates neurodegeneration: a review of mechanisms and clinical implications. | Front Nutr | 2026 | https://conductscience.org/library/papers/41693955 | PubMed |
| 41,420,771 | Piceatannol as a multi-target neuroprotective agent: mechanistic insights and therapeutic prospects in neurological disorders. | Metab Brain Dis | 2025 | https://conductscience.org/library/papers/41420771 | PubMed |
| 40,979,213 | Mitochondria-Associated Endoplasmic Reticulum Membranes in Health and Diseases. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/40979213 | PubMed |
| 40,874,597 | Therapeutic strategies for Huntington's disease: current approaches and future direction. | Neurodegener Dis Manag | 2026 | https://conductscience.org/library/papers/40874597 | PubMed |
| 40,599,237 | Oxidative Stress: Signaling Pathways, Biological Functions, and Disease. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/40599237 | PubMed |
| 40,295,342 | Advances in research on mitochondrial dysfunction in neurodegenerative diseases. | J Neurol | 2025 | https://conductscience.org/library/papers/40295342 | PubMed |
| 39,440,770 | Oxidative Stress-mediated Lipid Peroxidation-derived Lipid Aldehydes in the Pathophysiology of Neurodegenerative Diseases. | Curr Neuropharmacol | 2025 | https://conductscience.org/library/papers/39440770 | PubMed |
| 39,337,461 | New Insights into Mitochondria in Health and Diseases. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39337461 | PubMed |
| 39,333,347 | TRPV4 Channel in Neurological Disease: from Molecular Mechanisms to Therapeutic Potential. | Mol Neurobiol | 2025 | https://conductscience.org/library/papers/39333347 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| DNM1L | 10,059 | PubTator's text mining | https://conductscience.org/library/genes/10059 | NCBI Gene |
| FIS1 | 51,024 | PubTator's text mining | https://conductscience.org/library/genes/51024 | NCBI Gene |
| HTT | 3,064 | PubTator's text mining | https://conductscience.org/library/genes/3064 | NCBI Gene |
| PPARGC1A | 10,891 | PubTator's text mining | https://conductscience.org/library/genes/10891 | NCBI Gene |
| SIRT1 | 23,411 | PubTator's text mining | https://conductscience.org/library/genes/23411 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38982016
GET https://conductscience.org/api/papers/v1/38982016/references?page=2